Searchable abstracts of presentations at key conferences in endocrinology

ea0031p76 | Clinical practice/governance and case reports | SFEBES2013

Hypernatraemia with reset osmostat associated with secondary hypogonadism

Elhassan Yasir Mohamed , Ross Richard , Webster Jonathan

We report two cases of hypernatraemia with reset osmostat and pituitary dysfunction.A 35-year-old male was referred with Graves’ thyrotoxicosis associated with hypokalaemic periodic paralysis and an incidental serum sodium 154 mmol/l. He complained of polyuria and nocturia but denied excessive thirst and was otherwise well. Height was 193 cm with BMI 29.5. He had gynaecomastia and sparse body hair. He had a small 6 ml right testicle (originally und...

ea0028p151 | Neoplasia, cancer and late effects | SFEBES2012

Biochemical screening of adrenal incidentalomas may lead to early detection of MEN2A

Hamblin Ross , Gleeson Helena , Levy Miles

A forty-three year old woman (SR) presented to her GP in 2004 with persistent back pain. Following MRI, an incidental right adrenal mass was discovered. Laparoscopic adrenalectomy was performed in the private sector and histology was consistent with a phaeochromocytoma. No further biochemical investigations were performed at that stage. Six years later, her fourteen year old daughter presented with a solitary neck lump. Fine needle aspiration was inconclusive and subsequent le...

ea0009p36 | Growth and development | BES2005

SOCS proteins inhibit leptin signalling in MCF-7 cells

Fazeli M , Maamra M , Ross R

Introduction: Leptin is a pro-inflammatory cytokine and excess leptin in obesity may induce autoimmune disease. The suppressors of cytokine signalling (SOCS) are negative regulators of cytokine signalling and therefore a target for therapy. SOCS3 modulates leptin actions but there is no data regarding other SOCS proteins and leptin signalling.Aim: To develop a bioassay and examine the actions of SOCS proteins on leptin signalling.M...

ea0006p48 | Growth and development | SFE2003

QLS-H, A MEASURE OF QUALITY OF LIFE IN ADULT UK GHD PATIENTS

Patel S , Ross R , Edwards D

QLS-H is a new, weighted QoL questionnaire developed for patients with hypopituitarism. We evaluated QLS-H data from UK patients in the HypoCCs International surveillance study, and compared results with a sample of the general UK population (n=1090).The QLS-H questionnaire was administered at baseline and at yearly intervals. Scores were corrected for age and gender differences, and expressed as Z-scores based on UK-specific reference ranges. Using this...

ea0003s11 | Recent Advances in Biological Rhythms | BES2002

Photoperiodic regulation of the neuroendocrine system

Morgan P , Ross A , Mercer J , Barrett P

For many animals anticipation of future changes in environmental conditions is a critical adaptation for survival. Seasonal changes in reproductive activity, body weight and adiposity, metabolism and coat condition are examples of such adaptive physiology. Clearly each of these involves neuroendocrine control. The environmental cue that triggers these changes is photoperiod, which is translated into the hormonal signal, melatonin, a product of the pineal gland. A considerable ...

ea0002sp19 | <emphasis>Journal of Molecular Endocrinology</emphasis> Symposium: Receptor Antagonists | SFE2001

Growth Hormone Antagonists

Ross R , Justice S , Maamra M

The development of the growth hormone antagonist, Pegvisomant, is a story of modern drug design. The original observation was by John Kopchick, who noted that transgenic mice with a mutation in the third alpha helix of the GH molecule had a dwarf phenotype. This is the basis for the site 2 mutation (G120K) in the GH molecule that blocks GH signaling. At the same time the Genetech group of James Wells had characterised the crystal structure of the GH/receptor complex demonstrat...

ea0095oc10.2 | Oral Communications 10 | BSPED2023

A multidisciplinary approach to the growth hormone shortage

Burrows Ross , Foley Louise , Thirsk Claire

In January 2023 a Medicines Supply Notification (MSN) was issued by the Department of Health and Social Care (DHSC) regarding a shortage of Norditropin (somatropin) products. The MSN recommended that all patients on Norditropin FlexPro 10mg pens and NordiFlex pens (all strengths) be changed to Omnitrope SurePal. Each patient affected by the shortage needed to be informed of the issue, a new prescription issued, and training provided on the new device. Affected patients were id...

ea0021p352 | Steroids | SFEBES2009

Assessing adrenal status in patients before and after coronary artery bypass graft surgery

Debono Miguel , Sheppard Lorcan , Irving Sarah , Brookes Zoe , Newell-Price John , Ross John , Ross Richard

Background: Cortisol is an essential stress hormone and deficient patients suffering a systemic inflammatory response (SIR) will rapidly die if not replaced. However, controversy remains on the definition for a normal adrenal response in critically ill patients. We investigated cortisol status in patients undergoing coronary artery bypass surgery (CABG), surgery frequently associated with a SIR, varying in severity from sub-clinical, to life-threatening....

ea0095oc5.9 | Oral Communications 5 | BSPED2023

Home waking salivary cortisone to screen for adrenal insufficiency in children

Tavernier Mathilde , Ross Callum , Jessica Craig , Balagamage Chamila , Keevil Brian , Ross Richard , Debono Miguel , Elder Charlotte

Background: The current screening test for adrenal insufficiency (AI) involves patients attending hospital for an “early” morning serum cortisol sample, generally taken some considerable time after the child has woken. This risks missing the morning cortisol peak, leading to false positive results. It requires venepuncture, which is unpleasant for children. Saliva collection is non-invasive, simple and can be undertaken on waking at home, providing a...

ea0055p34 | Poster Presentations | SFEEU2018

Hyperkalaemia in Conn’s syndrome masking hyporeninaemic hypoaldosteronism

Rogers Rebecca , Burgess Neil , Ross Calum , Myint Kwin Swe

Background: Primary hyperaldosteronism (PHA) typically manifests as resistant hypertension, hypokalaemia and metabolic alkalosis. We present a case of PHA who subsequently exposed type 4 renal tubular acidosis (RTA) after surgical intervention.Case history: A 62 year old man underwent investigation for chronic resistant hypertension, which had failed to respond to titration of three antihypertensive agents including Perindopril, Amlodipine and Doxazosin....